Pharma & Healthcare

Pharmaceutical and healthcare market in Poland

Market analysis and development forecasts for 2018-2023

See our reports

Pharma & Healthcare

Pharmaceutical and healthcare market in Poland

Market analysis and development forecasts for 2018-2023

More information about pricing and contents available via phone:

+48 782 011 000 sales@pmrcorporate.com

Languages available:

ENPL

Sector:

Distribution

Scope:

PL

Pharmaceutical and healthcare market in Poland

Market analysis and development forecasts for 2018-2023

This report presents complete information and in-depth analysis of the Polish pharmaceutical market, broken down into the pharmacy and hospital segments and organised by category of ATC medicine. It contains information on all major manufacturers and best-selling products among Poland’s consumers.

The document includes analysis of the Polish healthcare segment, according to key aspects such as: total numbers of public and private hospitals, number of beds at each facility, the number of doctors by specialisation and the total value of health care spending in Poland.

Additional key elements of this report include pharmaceutical market value and development forecasts for the period 2018 to 2023 as well as information illustrating consumer preferences when purchasing medicines and choosing specific health care services.

Get access

What information does the report include?

Value of the entire pharmaceutical market and of each category of ATC pharmaceuticals
Market development forecasts for the period 2018 to 2023 – for the overall market and for several ATC categories
Major pharmaceutical manufacturers operating in Poland
Best-selling drugs and dietary supplements in Poland
The current sales totals for the most widely-used categories of ATC drugs, as well as sales forecasts for the coming years
Barriers and supporting factors that influence the development of the entire market and each individual category of medicines and health services
Detailed analysis of the current legal status, as well as possible future legal changes
Comprehensive data on the reimbursement process in Poland, including the application, refund rules, major practical problems, expenses for the refund, products of the highest refund to open reimbursement (pharmacy market), chemotherapy and drug programs
Analysis of generic substitution
List of drug programs existing in Poland, along with active substances
Poland’s national reimbursement policy, with presentation and impact analysis of the most recent changes to reimbursement lists and possible modifications in the future
Total spending of NFZ on medication refunds, including ATC classification category, the voivodship and the level of payment required from the patient
Epidemiological trends in Poland, including data describing the most common diseases and the most common cause of death in Poland
Consumer behaviour related to the purchase of drugs and use of specific healthcare services.

What makes this report stand out?

Monitoring the development and changes taking place in Poland’s pharmaceutical and healthcare market
Planning a new pharmaceutical or medical investment
Making decisions regarding financial support for entities operating in this market
Development of a product portfolio using ATC identification to determine categories that offer the highest growth potential
Analysis of potential investment and credit risks in this market
Performing merger or acquisition transactions
Analysis of current business operations, performance and growth plans of the competition
Preparation of corporate development strategies and budgets based on reliable forecasts for market development over the next five years
Estimating demand for various categories of medicines and types of healthcare services
Preparing to enter the pharmaceutical and medical market in Poland
Beginning business operations in new segments of this market.

Who can benefit from this analysis?

Financial institutions interested in the pharmaceutical and healthcare market in Poland, including banks, brokerage houses and investment funds
Consulting companies, research agencies, governments and research bodies that monitor the Polish pharmaceutical and medical industry
Marketing agencies serving pharmaceutical and medical companies
Drug manufacturers and producers operating in the market
Pharmaceutical distributors
Hospitals, both public and non-public
Non-hospital providers of healthcare services.

STEP 01

Contact the seller:

Once you have selected the report you are interested in, please contact our sales team.

You will receive detailed information about the publication, price, and terms of purchase.

STEP 02

Filling out the form:

After accepting the offer, you will receive a link to the order form with a request to fill it out.

STEP 03

Finalizing your purchase:

After paying the invoice, you will receive immediate access to the report on the mypmr.pro platform, provided that the report has already been published.

In the case of pre-sale reports, publication takes place on the announced date – the material will then automatically appear in your account.

Already have an account? Log in and go to the customer panel. New users go through a short registration process when making their first purchase.
If you have any questions, please email us at sales@pmrcorporate.com or contact us by phone.